13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001846444
Total reported value
$613.5M
$613.5M
20 檔
54.3%
In Q3 2025, Sands Capital Alternatives, LLC's U.S. equity holdings reached a combined market value of $613.5M, distributed across 20 disclosed stock positions.
In Q3 2025, Sands Capital Alternatives, LLC displayed an active expansion posture, initiating 1 new positions and adding to 8 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NU | Nu Holdings Ltd. | Stock-Financials | 25.17% | -6.85% | — | |
| 2 | KVYO | Klaviyo Inc-a | Stock-Other | 21.33% | -7.19% | — | |
| 3 | BBNX | Beta Bionics Inc | Stock-Other | 15.54% | +0.65% | — | |
| 4 | CPNG | Coupang Inc | Stock-Consumer Disc | 5.61% | -0.78% | -6.36% | |
| 5 | DASH | Doordash Inc - A | Stock-Consumer Disc | 5.37% | -0.13% | -76.35% | |
| 6 | IOT | Samsara Inc-cl A | Stock-Tech | 4.89% | -1.49% | +36.59% | |
| 7 | IKT | Inhibikase Therapeutics Inc | Stock-Other | 3.89% | -0.88% | — | |
| 8 | DDOG | Datadog Inc - Class A | Stock-Tech | 3.70% | +1.03% | — | |
| 9 | MNDY | monday.com Ltd. | Stock-Tech | 2.48% | -0.14% | — | |
| 10 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 2.21% | -0.55% | — | |
| 11 | CRWD | Crowdstrike Holdings Inc - A | Stock-Tech | 1.68% | — | — | |
| 12 | SNOW | Snowflake Inc | Stock-Tech | 1.33% | +0.29% | — | |
| 13 | ABOS | Acumen Pharmaceuticals Inc | Stock-Other | 1.28% | -0.46% | — | |
| 14 | TOST | Toast Inc-class A | Stock-Tech | 1.25% | -0.25% | — | |
| 15 | TXG | 10x Genomics Inc-class A | Stock-Other | 1.23% | +0.58% | — | |
| 16 | BIOA | Bioage Labs Inc | Stock-Other | 1.01% | -0.13% | — | |
| 17 | ACRV | Acrivon Therapeutics Inc | Stock-Other | 0.84% | -0.04% | — | |
| 18 | TSHA | Taysha Gene Therapies Inc | Stock-Other | 0.52% | +0.03% | — | |
| 19 | CADL | Candel Therapeutics Inc | Stock-Other | 0.45% | +0.21% | — | |
| 20 | FIG | Figma Inc-cl A | Stock-Other | 0.21% | -0.02% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | NU | Nu Holdings Ltd. | +7.2% | — | Add |
| 2 | BBNX | Beta Bionics Inc | +6.3% | — | Add |
| 3 | IOT | Samsara Inc-cl A | +2.5% | +36.59% | Add |
| 4 | CPNG | Coupang Inc | +1.1% | -6.36% | Trim |
| 5 | DDOG | Datadog Inc - Class A | +0.8% | — | Add |
| 6 | SNOW | Snowflake Inc | +0.4% | — | Add |
| 7 | ABOS | Acumen Pharmaceuticals Inc | +0.4% | — | Unchanged |
| 8 | CRWD | Crowdstrike Holdings Inc - A | +0.3% | — | Add |
| 9 | BIOA | Bioage Labs Inc | +0.3% | — | Unchanged |
| 10 | TSHA | Taysha Gene Therapies Inc | +0.3% | — | Unchanged |
| 11 | TXG | 10x Genomics Inc-class A | +0.2% | — | Unchanged |
| 12 | TARS | Tarsus Pharmaceuticals Inc | +0.1% | — | Unchanged |
| 13 | CADL | Candel Therapeutics Inc | -0.1% | — | Unchanged |
| 14 | ACRV | Acrivon Therapeutics Inc | -0.2% | — | Unchanged |
| 15 | TOST | Toast Inc-class A | -0.5% | — | Trim |
| 16 | MNDY | monday.com Ltd. | -0.5% | — | Add |
| 17 | IKT | Inhibikase Therapeutics Inc | -2% | — | Unchanged |
| 18 | KVYO | Klaviyo Inc-a | -4.2% | — | Add |
| 19 | DASH | Doordash Inc - A | -11.7% | -76.35% | Trim |
| 20 | PATH | Uipath Inc - Class A | — | EXIT | Sold out |
| 21 | FIG | Figma Inc-cl A | — | NEW | New buy |
According to official SEC Form 13F filings, Sands Capital Alternatives, LLC reported a total U.S. public equity portfolio value of $613.5M across 20 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including NU, KVYO, BBNX) accounted for 54.3% of total reported equity market value during Q3 2025.
Top New Position Initiated
FIG
市值: $948.5K
Top Position Liquidated / Trimmed
PATH
前期市值: $4.1M
During Q3 2025, Sands Capital Alternatives, LLC's top holdings by market value included NU (25.2%)、KVYO (21.3%)、BBNX (15.5%). The largest single position, NU, represented 25.2% of total portfolio value.
In Q3 2025, Sands Capital Alternatives, LLC made 13 total portfolio adjustments, initiating 1 new buys, adding to 8 positions, trimming 3 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.